ASCO2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

ASCO2025
Jun 15, 2025, 12:28 | Blog
Dora L. Vallejo-Ardila: Raising the Standard - Australian Clinical Trials Shine at ASCO 2025 Annual Meeting
Dora L. Vallejo - Ardila, Senior Medical Monitor/ Clinical Research Physician at Avance Clinical, shared…
Jun 14, 2025, 17:38 | Blog
Jemma Arakelyan Addressed Impact of Conflict on Cancer Care and Urgent Need For Innovation in Crisis-Affected Regions at ASCO25 - The Babak Lab
The Babak Lab shared a post on LinkedIn: "Proud Moment from ASCO 2025 – Chicago…
Jun 6, 2025, 07:28 | Blog
Sibylle Loibl: First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer
Sibylle Loibl, Chief Executive Officer of GBG Forschungs GmbH, shared a post on LinkedIn: "Breaking…
Jun 5, 2025, 10:08 | Insight
Erika Hamilton Expresses Gratitude to ASCO Team For ASCO 2025 Annual Meeting
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at the Sarah Cannon…
Jun 5, 2025, 09:39 | Blog
Alique Topalian: Thank You MedicalResearch for Highlighting Our Abstract From ASCO2025
Alique Topalian, Research Scientist of Survivorship and Supportive Services at University of Cincinnati Cancer Center,…
Jun 5, 2025, 09:28 | Blog
Jasmine Kamboj Congratulated Frank Sinicrope for the ASCO25 Plenary Session on ATOMIC Trial Results
Jasmine Kamboj, Medical Oncologist and Hematologist at Mayo Clinic, Podcast Editor and Host of the…
Jun 5, 2025, 05:59 | Blog
A Vibrant Few Days at The ASCO2025 Annual Meeting in Chicago - SPCC
SPCC (Sharing Progress in Cancer Care) shared a post on LinkedIn: "A vibrant few days…
Jun 5, 2025, 04:28 | Blog
Shameel Shafqat Presents Immunotherapy Research in Recurrent Gliomas at ASCO 2025
Shameel Shafqat, Research Scholar at Mayo Clinic, posted on LinkedIn: "Grateful to have attended ASCO2025…
Jun 4, 2025, 11:10 | Blog
Olubukola Ayodele: What this week at ASCO25 has meant, not just as an Oncologist, but as a human being
Olubukola Ayodele, Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, shared a post…
Jun 4, 2025, 06:08 | Blog
Han Chong Toh Recaps ASCO 2025 Highlights in Immunotherapy and AI
Han Chong Toh, Deputy Chief Executive Officer at National Cancer Centre Singapore, shared a post…
Jun 4, 2025, 06:01 | Blog
Miriam Mutebi: Applications are Open for VOICE Webinar 1 - Advocacy and Meaningful Engagement
Miriam Mutebi, Breast Surgical Oncologist and Assistant Professor in the Department of Surgery at the…
Jun 2, 2025, 12:11 | Blog
Chiara Mercinelli: My Mentor Andrea Necchi Delivered a Brilliant Presentation Today at ASCO2025
Chiara Mercinelli, GU Medical Oncologist at IRCCS San Raffaele Hospital, shared a post on X:…
Jun 2, 2025, 10:30 | Oncolibrary
VERIFY Trial: Rusfertide Significantly Reduces Phlebotomy Need and Improves Symptoms in Polycythemia Vera
  Polycythemia vera (PV) is a chronic myeloproliferative neoplasm marked by excessive production of red…
Jun 2, 2025, 07:52 | Blog
Olubukola Ayodele: Wrapped up Day 2 of ASCO2025
Olubukola Ayodele, Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, posted on…
Jun 2, 2025, 07:08 | Blog
Roupen Odabashian: Benchmarking LLM Performance on Breast Oncology Multiple-Choice Questions
Roupen Odabashian, Hematology/Oncology Fellow at the Karmanos Cancer Institute, posted on LinkedIn: "New Study at…
Jun 1, 2025, 10:54 | Blog
Shushan Hovsepyan: Presented my Poster on Sarcoma Clinical Trial Inequities at ASCO2025
Shushan Hovsepyan, Editor-in-Chief of OncoDaily Medical Journal and Co-Chair of the International Society of Pediatric Oncology…
Jun 1, 2025, 10:41 | Oncolibrary
ATOMIC Trial Results at ASCO 2025: Atezolizumab Significantly Improves Disease-Free Survival in Stage III dMMR Colon Cancer
Standard adjuvant chemotherapy for stage III colon cancer typically involves fluoropyrimidine combined with oxaliplatin. For…
Jun 1, 2025, 09:21 | Blog
Amalya Sargsyan: So great to reunite with ASCO IDEA2024 friends at ASCO2025
Amalya Sargsyan, Medical Oncologist at Yeolyan Center, shared a post on LinkedIn: "So great to reunite…
Jun 1, 2025, 06:36 | Blog
Sid Sadler: New Era for Renal Cell Carcinoma Patients
Sid Sadler, Cancer Survivor, posted on X: "A new era for renal cell carcinoma patients!…
Jun 1, 2025, 05:46 | Blog
Olubukola Ayodele: Day 2 of ASCO2025
Olubukola Ayodele, Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, posted on…
Jun 1, 2025, 03:12 | Oncolibrary
KEYNOTE-630 Phase 3 Trial at ASCO 2025: Adjuvant Pembrolizumab Does Not Significantly Improve Outcomes in High-Risk Resected Cutaneous Squamous Cell Carcinoma
Patients with high-risk locally advanced cutaneous squamous cell carcinoma (LA cSCC) face substantial risk of…
Jun 1, 2025, 02:34 | Blog
Tanja Obradovic: HARMONi Trial - Topline Results Reveal Positive PFS for Ivonescimab in NSCLC
Tanja Obradovic, Oncology Medical Strategy Advisor at Mercurial AI, shared a post on LinkedIn: "High…
May 31, 2025, 18:35 | Insight
Chris Boshoff: BREAKWATER Study Halves Risk of Death in BRAF V600E-Mutated Metastatic Colorectal Cancer
Chris Boshoff, Chief Scientific Officer and President of Research and Development at Pfizer, shared a…
May 31, 2025, 03:59 | Opinion
Matthew Kurian: Day 0 at ASCO 2025 and the Energy is Already Electric
Matthew Kurian, Assistant professor of Medicine at the University of Kentucky College of Medicine, shared…
May 31, 2025, 03:17 | Blog
Isabel Mestres Highlighted City Cancer Challenge Initiatives and Global Engagements at ASCO 2025
Isabel Mestres, CEO of City Cancer Challenge (C/Can), shared a post on LinkedIn: "Landing as I…
May 30, 2025, 15:13 | Blog
Vivek Subbiah: Exhilarating Discussions with Erika Hamilton at the ASCO 2025 Annual Meeting
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared a…
May 30, 2025, 05:42 | Blog
Colorectal Cancer Alliance and PeerView Live at ASCO 2025 on Systemic Therapy Regimens in CRC
Colorectal Cancer Alliance shared a post on LinkedIn: "The Colorectal Cancer (CRC) treatment landscape has…
May 29, 2025, 13:47 | Opinion
Robin Zon and Andy Guinigundo Highlighted the Importance of Team Attendance at ASCO 2025
Robin Zon, President of ASCO 2024-2025, shared a post by Andy Guinigundo, Vice President for…
May 29, 2025, 13:32 | Opinion
List of 10 ADC Presentations Not to Miss at the ASCO 2025 Curated by Paolo Tarantino and Raffaele Colombo
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn: "Antibody-drug conjugates are…
May 29, 2025, 03:51 | Blog
Cesar Perez: Exciting update in lung cancer treatment being presented at ASCO2025
Cesar Perez, Director of Drug Development at Lake Nona DDU of Florida Cancer Specialists and…
May 28, 2025, 16:43 | Blog
Tanja Obradovic Highlights Positive ASCENT-03 Results for Trodelvy Ahead of ASCO 2025
Tanja Obradovic, Oncology Medical Strategy Advisor at Mercurial AI, shared a post on LinkedIn: "ASCO2025…
May 28, 2025, 09:58 | Science
Mohit Manrao: AstraZeneca will share trial results from SERENA-6, MATTERHORN and DESTINY-Breast09 at ASCO 2025
Mohit Manrao, SVP, Head of US Oncology at AstraZeneca, shared a post on LinkedIn: "This…
May 27, 2025, 12:04 | Blog
Xiuning Le: Excited about our upcoming presentations at ASCO2025
Xiuning Le, Deputy Section Chief of Thoracic Medical Oncology at MD Anderson Cancer Center, shared a…
May 27, 2025, 02:53 | Blog
Yelak Biru: Practical Guide to Clinical Trial Accessibility - Making Trial Participation a Standard of Care
Yelak Biru, President and Chief Executive Officer at International Myeloma Foundation, shared a post on…
May 24, 2025, 20:10 | Blog
Miriam Mutebi: Join AORTIC Networking Reception at ASCO 2025 in Chicago
Miriam Mutebi, Breast Surgical Oncologist and Assistant Professor in the Department of Surgery at the…
May 24, 2025, 18:24 | Insight
Cizzle Bio’s CIZ1B Lung Cancer Test Could Save Medicare $518 Million a Year While Improving Early Detection
Cizzle Bio shared a post on X: "New ASCO2025 study: Cizzle Bio’s CIZ1B lung cancer…
May 15, 2025, 12:38 | Blog
Alique Topalian: Join us for the first INSPiRE meetup at ASCO 2025
Alique Topalian, Research Scientist of Survivorship and Supportive Services at University of Cincinnati Cancer Center,…
May 9, 2025, 14:01 | Blog
Meet the ASCO25 Featured Voices
Each year, the American Society of Clinical Oncology (ASCO) Annual Meeting brings together the brightest…
Apr 27, 2025, 17:06 | Blog
Tiago Biachi discusses aspirin's role in colorectal cancer and ATOMIC trial insights
Tiago Biachi, Medical Oncologist and Associate Member at Moffitt Cancer Center, shared a post on…
Apr 27, 2025, 12:20 | Blog
Common Sense Oncology will be at the ASCO 2025
Common Sense Oncology shared a post on X: "CSO will be at ASCO 2025! Join our…
Apr 24, 2025, 14:10 | Blog
Arturo Loaiza-Bonilla to Present at ASCO/ESMO Joint Session on Biomarker-Driven Therapeutics
Arturo Loaiza-Bonilla, Systemwide Chief of Hematology and Oncology at St. Luke's University Health Network, shared…
Apr 4, 2025, 07:37 | Blog
Rahul Gosain: Less than 2 months to ASCO25
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared…
Apr 3, 2025, 09:56 | Blog
Rajesh Sharma: My abstract got accepted for a poster presentation at the ASCO2025
Rajesh Sharma, Managing Director at Mice Ideas, shared a post on LinkedIn: "Excited to announce…
Jul 14, 2024, 20:58 | Blog
Nominate a colleague for a 2025 ASCO Special Award
ASCO (American Society of Clinical Oncology) posted on LinkedIn:             …
Jun 11, 2024, 11:32 | Insight
Shushan Hovsepyan: Just some thoughts out loud after an incredibly intense and fulfilling ASCO24
Shushan Hovsepyan shared on LinkedIn: “Just some thoughts out loud after an incredibly intense and…
All: 45 Posts: 1 - 100
Special Coverage